You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 26, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Jing Li1, Rong Fu2, Liping Yang3
1Department of Hematology, Tianjin Medical University General HospitalTianjin 300052, China; Department of Hematology, Shangyu People's HospitalShangyu 312300, Shaoxing, Zhejiang, China.
Serum miR-21 is elevated in diffuse large B cell lymphoma (DLBCL) and indicates a poorer prognosis. This microRNA shows potential as a novel biomarker for predicting DLBCL patient survival outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: